Location History:
- Belmont, MA (US) (2014 - 2021)
- San Francisco, CA (US) (2020 - 2024)
Company Filing History:
Years Active: 2014-2024
Title: Christina N Carrigan: Innovator in Cancer Therapy
Introduction
Christina N Carrigan is a prominent inventor based in Belmont, MA (US), known for her significant contributions to cancer therapy. With a total of 11 patents to her name, she has made remarkable strides in the field of immunology and oncology.
Latest Patents
Among her latest patents is a method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate. This invention relates to antibodies that bind to the human folate receptor and includes diagnostic assays for folate receptor 1-based therapies. Additionally, she has developed a method for identifying ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody. This invention also focuses on antibodies that bind to the human folate receptor and provides methods for monitoring therapy.
Career Highlights
Christina works at Immunogen, Inc., where she continues to innovate and develop new therapeutic strategies. Her work has been instrumental in advancing the understanding and treatment of cancers that express the folate receptor.
Collaborations
Some of her notable coworkers include Olga Ab and Daniel J Tavares, who contribute to her research and development efforts.
Conclusion
Christina N Carrigan's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer therapy. Her patents and ongoing research are paving the way for more effective treatments and improved patient outcomes.